Bausch Health Cos Net Change in Intangible Assets 2010-2025 | BHC
Bausch Health Cos net change in intangible assets from 2010 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
Bausch Health Cos Annual Net Change in Intangible Assets
(Millions of US $) |
| 2024 |
$-3 |
| 2023 |
$-57 |
| 2022 |
$-50 |
| 2021 |
$-14 |
| 2020 |
$-7 |
| 2019 |
$-8 |
| 2018 |
$-78 |
| 2017 |
$-165 |
| 2016 |
$-56 |
| 2015 |
$-68 |
| 2014 |
$-179 |
| 2013 |
$-70 |
| 2012 |
$-74 |
| 2011 |
$-327 |
| 2010 |
$-85 |
| 2009 |
$-762 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.646B |
$9.625B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
